Projects per year
The digital medicine group will align with the digital health strategies in Luxembourg and develop digital health concepts that accelerate innovative digital healthcare technology solutions and health informatics. Thus, we will contribute to the innovations in digital healthcare solutions and improve healthcare, by enabling fast, efficient and transparent information for the patient and their healthcare team.
The digital medicine group started in March 2021 and is supported by the FNR-PEARL Program at the LCSB (Luxembourg Center for System Biology) at the University of Luxembourg, the LIH (Luxembourg Institute of Health) and the dMed Research Clinic at the CHL (Centre Hospitalier de Luxembourg).
With a strong focus on Parkinson's disease, the PEARL project aims to understand how wearable sensors and smartphone-applications can support patients’ lives and be integrated into a multidisciplinary healthcare team.
We build on the existing Luxembourg Parkinson's Study consisting of more than 1600 PD patients and healthy controls within the NCER-PD programme coordinated by Prof Rejko Krüger. Here, the ParkinsonNet concept already aims to connect patients, hospitals, primary care doctors and specialists, as well as therapists and other healthcare providers. The first digital healthcare solutions tested in this environment will mainly address mobility and gait, but also other relevant functional impairments in Parkinson's Patients, including cognitive impairment, sleep disturbances, and other non-motor functions. Our collaborating partners from industry and academia will provide their digital solutions and we will test their medical effect, but at the same time also the acceptance of patients and healthcare provider. We will also study the ethical, legal and social impact of these "data-driven" services in order to understand how the highest benefit can be reached with an acceptable risk for an individual patient and the society.
In the near future, the learnings from Parkinson will be transferred to other diseases. Digital Medicine aims to understand and shape the future of medicine. It is exciting to see how many solutions can be found when you ask the right question.
Dive into details
Select a country/territory to view shared publications and projects
30/06/21 → 29/06/26
Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practiceTönges, L., Buhmann, C., Klebe, S., Klucken, J., Kwon, E. H., Müller, T., Pedrosa, D. J., Schröter, N., Riederer, P. & Lingor, P., 15 Apr 2022, (E-pub ahead of print) In: Journal of Neural Transmission.
Research output: Contribution to journal › Review article › peer-reviewOpen Access
Ollenschläger, M., Kluge, F., Müller-Schulz, M., Püllen, R., Möller, C., Klucken, J. & Eskofier, B. M., 3 Mar 2022, (E-pub ahead of print) In: European Geriatric Medicine.
Research output: Contribution to journal › Article › peer-reviewOpen Access
& 12 others, , 28 Jul 2021, In: Brain. 144, 6, p. e58
Research output: Contribution to journal › Comment/debateOpen Access